Sites: CDL-Oxford, CDL-Toronto, CDL-Vancouver, CDL-Wisconsin
Stream: Advanced Therapies
Andrea Sotak is a leading healthcare investing professional with a more than 20-year track record of assessing the potential of therapeutics. She is the former President and Chief Investment Officer of DRI Capital and currently serves as the Chair of its Advisory Committee. Andrea has been responsible for the development and execution of DRI’s investment strategies and took a leading role in the execution of all investments completed in DRI’s private equity funds. In addition to leading the firm’s investment team, she set up and then led its investor relations and operations functions. Andrea was instrumental in raising multiple private equity funds and the execution of numerous debt financings.
Prior to joining DRI, Andrea’s life sciences background included several years with Aventis Pasteur and Allelix Biopharmaceuticals Inc.
Andrea acts as a mentor to seed-stage healthcare companies across North America through her participation in several incubator programs. She is also a member of the Advisory Board at the Smith School of Business, volunteers her time at the University of Waterloo, and is involved with a number of initiatives that champion women in STEM. Andrea received a B.Sc. in Biochemistry from the University of Waterloo and an MBA from Queen’s University.